Clinical Trial Update: Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dronedarone for atrial fibrosis progression and atrial fibrillation recurrence was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dronedarone (dronedarone)

Snippet

Sponsor: Tulane University School of Medicine | Conditions: Atrial Fibrillation, Atrial Fibrillation Recurrent | Phase 4 | Status: TERMINATED | Results posted: 2025-10-16